ArticleBMC neurology2026

Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod.

Jingting Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.